Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes - AIM-HIGH


The goal of this trial was to compare treatment with extended-release niacin versus placebo among statin-treated patients with established (non-acute) vascular disease and optimally treated low-density lipoprotein cholesterol (LDL-C) and with low high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides.